CYLIOS Trademark

Trademark Overview

On Friday, September 20, 2013, a trademark application was filed for CYLIOS with the United States Patent and Trademark Office. The USPTO has given the CYLIOS trademark a serial number of 86070896. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 31, 2017. This trademark is owned by Novartis AG. The CYLIOS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and biological preparations for the prevention or treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system and the genitourinary system, for the treatment of inflammatory disorders; pharmaceutical and biological preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical and biological preparations for the prevention and treatment of ocular disorders and diseases, for the treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; anti-fungal, anti-infective, antiviral and antibiotic preparations
cylios

General Information

Serial Number86070896
Word MarkCYLIOS
Filing DateFriday, September 20, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 31, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 29, 2014

Trademark Statements

Goods and ServicesPharmaceutical and biological preparations for the prevention or treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system and the genitourinary system, for the treatment of inflammatory disorders; pharmaceutical and biological preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical and biological preparations for the prevention and treatment of ocular disorders and diseases, for the treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; anti-fungal, anti-infective, antiviral and antibiotic preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 27, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Monday, July 31, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 31, 2017ABANDONMENT - NO USE STATEMENT FILED
Thursday, January 19, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 18, 2017EXTENSION 5 GRANTED
Thursday, December 22, 2016EXTENSION 5 FILED
Thursday, December 22, 2016TEAS EXTENSION RECEIVED
Tuesday, July 5, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 4, 2016EXTENSION 4 GRANTED
Friday, June 17, 2016EXTENSION 4 FILED
Friday, June 17, 2016TEAS EXTENSION RECEIVED
Thursday, January 21, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 20, 2016EXTENSION 3 GRANTED
Monday, December 21, 2015EXTENSION 3 FILED
Monday, December 21, 2015TEAS EXTENSION RECEIVED
Friday, July 17, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 16, 2015EXTENSION 2 GRANTED
Tuesday, June 16, 2015EXTENSION 2 FILED
Wednesday, July 15, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 16, 2015TEAS EXTENSION RECEIVED
Wednesday, April 8, 2015ASSIGNED TO EXAMINER
Thursday, December 25, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 23, 2014EXTENSION 1 GRANTED
Tuesday, December 23, 2014EXTENSION 1 FILED
Tuesday, December 23, 2014TEAS EXTENSION RECEIVED
Tuesday, June 24, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 29, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 29, 2014PUBLISHED FOR OPPOSITION
Wednesday, April 9, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 26, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, March 20, 2014ASSIGNED TO LIE
Thursday, March 6, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 6, 2014EXAMINER'S AMENDMENT ENTERED
Thursday, March 6, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, March 6, 2014EXAMINERS AMENDMENT E-MAILED
Thursday, March 6, 2014EXAMINERS AMENDMENT -WRITTEN
Friday, December 20, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 20, 2013NON-FINAL ACTION E-MAILED
Friday, December 20, 2013NON-FINAL ACTION WRITTEN
Thursday, December 19, 2013ASSIGNED TO EXAMINER
Friday, September 27, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, September 24, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

cylios system disorders diseases treatment preparations pharmaceutical biological prevention anti bacteria